<s> Ciba-Geigy Ltd. and Chiron Corp. said they extended their offer for Connaught BioSciences Inc. , valued at 866 million Canadian dollars -LRB- US$ 736 million -RRB- to Oct. 27 . </s>
<s> The companies earlier said they did n't want to raise their offer to match a rival bid by Institut Merieux S.A. of C$ 37 a share , or C$ 942 million . </s>
<s> But they said the C$ 30-a-share bid , which was due to expire Monday , may still be extended or varied . </s>
<s> Merieux , a vaccine manufacturer based in Lyon , France , is 51%-held by French state-owned Rhone-Poulenc S.A . </s>
<s> Ciba-Geigy is a major pharmaceutical concern based in Basel , Switzerland . </s>
<s> Chiron , another pharmaceutical concern , is based in Emeryville , Calif . </s>
<s> Connaught is a biotechnology research and vaccine manufacturing concern . </s>
<s> Institut Merieux 's bid for Toronto-based Connaught has run into problems with the Canadian government , which told Merieux last week that it was n't convinced that the proposed acquisition would be of `` net benefit '' to Canada . </s>
<s> Merieux officials are expected to meet with federal officials in Ottawa today to discuss the decision . </s>
